Apollo Hospitals acquire 50 percent stake in Medics Super Speciality Hospital for Rs 91 crore

Published On 2018-07-07 08:23 GMT   |   Update On 2018-07-07 08:23 GMT

New Delhi: Apollo Hospitals said it has acquired 50 percent stake in a Lucknow-based 330-bed super speciality hospital project for a consideration of Rs 91 crore.


The acquisition of 50 percent stake in Medics Super Speciality Hospital would help the Chennai-based healthcare major to consolidate its position in Uttar Pradesh, Apollo Hospitals Enterprise said in a regulatory filing.

The project, which is spread over a 3.5 lakh square feet area in Lucknow, is expected to be commissioned by the third quarter of the current financial year, it added.

"The acquisition of the 50 percent equity stake is through a primary issuance of shares by Medics for a consideration of Rs 91 crore which would be utilized towards hospital commissioning and related expenses," Apollo Hospitals said.

Apollo Hospitals Managing Director Suneeta Reddy said, "In order to strengthen Apollo's position in the UP region, Apollo was on the lookout for acquisitions to grow inorganically and considers the acquisition as the right choice given the promoters background and expertise in healthcare services in Lucknow."

The healthcare provider expects to leverage its proven track record of performance and operational capabilities to drive growth and profitability at Medics and create long-term value for the shareholders, she added.

Medics Super Speciality Hospital's founder and chairman Sushil Gattani said there is a potential to develop Lucknow as a cost-effective medical travel destination.

Lucknow already attracts around 5-8 percent of its patients from Nepal, he added.
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News